Skip to content

Patient’s Preferences in the Treatment of Vitiligo – A Discrete Choice Experiment

Patient’s Preferences in the Treatment of Vitiligo – A Discrete Choice Experiment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00032201
Enrollment
150
Registered
2023-07-26
Start date
2024-05-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L80

Interventions

Group 1: This study consists of the following elicitations: 1) Qualitative guided semi-structured pilot interviews (Q3 2023
N = 5). 2) Qualitative pretest interviews to test a survey instrument using the think-aloud method (Q3 2023
N = 5). 3) Conduct a discrete choice experiment using a quantitative survey via an online questionnaire (Q3 2023-2024
about N = 150)

Sponsors

Hochschule Neubrandenburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis: Vitiligo Resident in Germany Able to read and understand German

Exclusion criteria

Exclusion criteria: Age <18 years Diagnosis: No Vitiligo Not resident in Germany Not able to read and understand German

Design outcomes

Primary

MeasureTime frame
To elicit the trade-offs that vitiligo patients make when treatment is clinically indicated and thus identify the weighting of characteristics of a treatment (preferences).

Secondary

MeasureTime frame
Secondary objectives are benefit-risk assessment to estimate patient maximum level of acceptable risk of treatment-related sides effects, the overall comparison to assess the relative importance of attributes and adherence to identify key attributes that affect patients’ willingness to adhere to topical treatment options. Exploratory objectives are the analysis of heterogeneity to assess how preferences differ based on respondents' characteristics and the identification of personas or subgroups to explore and explain heterogeneity based on the correlation between preferences and sociodemographic information, experience-based treatment history and attitudes of the respondents.

Countries

Germany

Contacts

Public ContactAxel Mühlbacher

Hochschule Neubrandenburg

muehlbacher@hs-nb.de+49039556932512

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026